JPS5219632U - - Google Patents

Info

Publication number
JPS5219632U
JPS5219632U JP10600375U JP10600375U JPS5219632U JP S5219632 U JPS5219632 U JP S5219632U JP 10600375 U JP10600375 U JP 10600375U JP 10600375 U JP10600375 U JP 10600375U JP S5219632 U JPS5219632 U JP S5219632U
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP10600375U
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP10600375U priority Critical patent/JPS5219632U/ja
Publication of JPS5219632U publication Critical patent/JPS5219632U/ja
Pending legal-status Critical Current

Links

Classifications

    • Y02E60/12

Landscapes

  • Secondary Cells (AREA)
JP10600375U 1975-07-30 1975-07-30 Pending JPS5219632U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP10600375U JPS5219632U (en) 1975-07-30 1975-07-30

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10600375U JPS5219632U (en) 1975-07-30 1975-07-30

Publications (1)

Publication Number Publication Date
JPS5219632U true JPS5219632U (en) 1977-02-12

Family

ID=28587275

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10600375U Pending JPS5219632U (en) 1975-07-30 1975-07-30

Country Status (1)

Country Link
JP (1) JPS5219632U (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53103525U (en) * 1977-01-26 1978-08-21
US10934244B2 (en) 2015-06-15 2021-03-02 Nmd Pharma A/S Compounds for use in treating neuromuscular disorders
US11147788B2 (en) 2017-12-14 2021-10-19 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US11591284B2 (en) 2017-12-14 2023-02-28 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US11730714B2 (en) 2017-12-14 2023-08-22 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53103525U (en) * 1977-01-26 1978-08-21
US10934244B2 (en) 2015-06-15 2021-03-02 Nmd Pharma A/S Compounds for use in treating neuromuscular disorders
US11147788B2 (en) 2017-12-14 2021-10-19 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US11591284B2 (en) 2017-12-14 2023-02-28 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US11730714B2 (en) 2017-12-14 2023-08-22 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders

Similar Documents

Publication Publication Date Title
FR2334637B1 (en)
CH603926A5 (en)
CH595405A5 (en)
BG21639A1 (en)
BG21736A1 (en)
BG22009A1 (en)
BG22195A1 (en)
BG22551A1 (en)
BG22771A1 (en)
BG23303A1 (en)
CH586879A5 (en)
CH587680A5 (en)
CH587714A5 (en)
CH590123A5 (en)
CH590460A5 (en)
CH591765A5 (en)
CH591966A5 (en)
CH592898A5 (en)
CH604436A5 (en)
CH593414A5 (en)
CH593446A5 (en)
CH594114A5 (en)
CH594370A5 (en)
CH594517A5 (en)
CH594830A5 (en)